Zelira Therapeutics Limited (OTCMKTS:ZLDAF – Get Free Report)’s share price was down 4.5% on Wednesday . The company traded as low as $0.26 and last traded at $0.26. Approximately 685 shares changed hands during mid-day trading, an increase of 72% from the average daily volume of 398 shares. The stock had previously closed at $0.27.
Zelira Therapeutics Price Performance
The stock has a 50-day moving average price of $0.26 and a two-hundred day moving average price of $0.29.
About Zelira Therapeutics
Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of various medical conditions in Australia and the United States. The company offers formulations under the HOPE brand in Australia, Washington, Pennsylvania, and Louisiana, as well as develops Zenivol, a cannabinoid-based medicine for treatment of chronic insomnia.
Featured Stories
- Five stocks we like better than Zelira Therapeutics
- Where Do I Find 52-Week Highs and Lows?
- Visa Beats Q3 Earnings Expectations, So Why Did the Market Panic?
- Using the MarketBeat Stock Split Calculator
- How Marvell Went From Short Target to Breakout Star
- With Risk Tolerance, One Size Does Not Fit All
- Palo Alto Networks: The All‑in‑One Cybersecurity Powerhouse
Receive News & Ratings for Zelira Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zelira Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
